Renal Insufficiency - PowerPoint PPT Presentation

1 / 88
About This Presentation
Title:

Renal Insufficiency

Description:

Renal Insufficiency TOPICS Introduction Acute renal failure Chronic renal failure Uremia Functions of kidney The kidneys excrete these compounds with water to make urine. – PowerPoint PPT presentation

Number of Views:665
Avg rating:3.0/5.0
Slides: 89
Provided by: 27123
Category:

less

Transcript and Presenter's Notes

Title: Renal Insufficiency


1
Renal Insufficiency
2
To be a great champion you must believe you are
the best. If youre not, pretend you are.!
Muhammad Ali
3
TOPICS
  • Introduction
  • Acute renal failure
  • Chronic renal failure
  • Uremia

4
Functions of kidney
The kidneys are a pair of small organs that lie
on either side of your spine at about waist
level. They act as filters that keep your blood
free of by-products and toxins.
  • The kidneys excrete these compounds with water to
    make urine.
  • They also eliminate excess body water while
    selectively reabsorbing useful chemicals and
    allowing waste to pass freely into the bladder as
    urine.
  • They allow you to continue to consume a variety
    of foods, drugs, vitamins and supplements,
    additives, and excess fluids without worry that
    toxic by-products will build up to harmful levels.

5
  • The kidneys play an essential role in maintaining
    electrolyte and acid-base balance.
  • They produce some hormones including renin,
    prostaglandins, erythropoietin, and active
    vitamin D.
  • So, they are crucial in the regulation of blood
    pressure, formation of matured red blood cells,
    and metabolism of calcium and phosphorus.

6
Functions of the Kidney
  • Waste excretion
  • Electrolyte balance
  • Fluid balance
  • pH
  • Osmolality
  • Hormone production

7
Anatomy of Kidney
8
(No Transcript)
9
Manifestation of renal dysfunction
  • Glomerulus
  • decreased GFR
  • glomerular filtration membrane permeability
    alteration
  • Renal tubule
  • concentrative function decline
    (hyposthennuria/isosthennuria)
  • water, electrolyte, acid-base disorder
  • others
  • Endocrine disorder
  • hypertension anemia renal
    osteodystrophy
  • others

10
??VitD3?????
  • ??? 25-??? 1a-???
  • 7-????? VitD3 25-(OH)VitD3
    1,25-(OH) 2VitD3
  • (??) (????)
    (????)

11
Acute Renal Failure, ARF
12
  • Definition
  • Etiology classification
  • Prerenal failure
  • Intrinsic renal failure
  • Post(obstructive) renal failure
  • Pathogenesis
  • Clinical manifestation
  • Therapy

13
Definition
  • Acute renal failure (ARF) is defined as a
    precipitous and significant (gt50) decrease in
    glomerular filtration rate (GFR) over a period of
    hours to days, with an accompany-ing accumulation
    of nitrogenous wastes in the body.

14
??????????
  •  ???????(acute renal failure,ARF)?????????????????
    ???????,?????????????????????????
  • ??????????GFR????,???????????????????????????????
    ??
  • ???????????????,?????(????????400ml)?????(????????
    400ml)?????????????,?????,??????,?????

15
Etiology
  • Pre-renal (70 of cases)
  • resulting from impaired blood flow to
    or oxygenation of the kidneys.
  • Intrinsic-renal (25 of cases)
  • resulting from injury to or
    malformation of kidney tissues.
  • Post-renal (lt5 of cases)
  • resulting from obstruction of urinary
    flow between the kidney and urinary meatus.

16
Causes
  • Prerenal failure - Diseases that compromise renal
    perfusion
  • Decreased effective arterial blood volume -
    Hypovolemia, CHF, liver failure, sepsis
  • Renal arterial disease - Renal arterial stenosis
    (atherosclerotic, fibromuscular dysplasia),
    embolic disease (septic, cholesterol)

17
???????????????

  • ?????
  • ?????(??????????????
  • ??????)???(?????)
  •  
  • ADH? ???????
    Ald?
  •  

  • ????
  • ?????
    ?????
  •  
    ?????
  •   ?????????
  •  
    GFR?
  •  

  • ????

18
  • Intrinsic renal failure - Diseases of the renal
    parenchyma, specifically involving the renal
    tubules, glomeruli, interstitium
  • ATN, ischemia, toxins (eg, aminoglycosides,
    radiocontrast, heme pigments, cisplatin, myeloma
    light chains, ethylene glycol)
  • Interstitial diseases - Acute interstitial
    nephritis, drug reactions, autoimmune diseases
    (eg, systemic lupus erythematosus SLE),
    infiltrative disease (sarcoidosis, lymphoma),
    infectious agents (Legionnaire disease,
    hantavirus)
  • Acute glomerulonephritis
  • Vascular diseases - Hypertensive crisis,
    polyarteritis nodosa, vasculitis

19
  • Postrenal failure - Diseases causing urinary
    obstruction from the level of the renal tubules
    to the urethra
  • Tubular obstruction from crystals (eg, uric acid,
    calcium oxalate, acyclovir, sulfonamide,
    methotrexate, myeloma light chains)
  • Ureteral obstruction - Retroperitoneal tumor,
    retroperitoneal fibrosis (methysergide,
    propranolol, hydralazine), urolithiasis,
    papillary necrosis
  • Urethral obstruction - Benign prostatic
    hypertrophy prostate, cervical, bladder,
    colorectal carcinoma bladder hematoma bladder
    stone obstructed Foley catheter neurogenic
    bladder.

20
Causes of ARF in tertiary care hospital setting
21
????????????
  • ???ARF (??????ARF )
  • ??????????????????????ARF??????? ?
  • ??ARF(?????ARF)
  • ?????????????????(acute tubular
    necrosis,ATN)????????????ARF??,??ARF?7580 ?
  • ???ARF
  • ??????????,????????????????

22
Pathogenesis of ARF
I. Renal hemodynamics factors
  • Decreased renal blood flow
  • Renal hypoperfusion
  • Vasoconstriction
  • Vascular obstruction
  • Redistribution of renal blood flow

23
II. Nephronal factors
  • Tubule injury
  • Tubule obstruction
  • Passive backflow

24
Acute Renal Failure, IntrinsicAcute Tubular
Necrosis
  • Renal hypoperfusion/ischemia
  • Nephrotoxic agents (both endogenous and
    exogenous)
  • Mortality 50
  • Bronchopulmonary infections, sepsis,
    cardiovascular disease, bleeding disorders
  • Complete Recovery 25, Incomplete 20, No
    Recovery 5

25
Acute Tubular NecrosisNephrotoxic Agents
  • Exogenous
  • Antibiotics
  • Contrast
  • Diuretics
  • Chemotherapeutics
  • Analgesics
  • Solvents, metals, chemicals
  • HIV meds
  • Antiulcer meds
  • Anesthetics
  • Endogenous
  • Pigment nephropathy
  • Crystal deposition
  • Tumor-specific syndromes

26
Acute Tubular Necrosis
Cell Hypoxia
Depletion of ATP
Hypoxanthine
Impaired function Of plasma membranes And ATPases
Ca imbalance
Na-K imbalance
Cell Swelling
Disrupt cytoskeleton Activate phospholipases Forma
tion of xanthine oxidase Uncoupling of oxidative
phosphorylation
Disrupt lipid bilayer
Reperfusion injury Free radicals
27
Acute Tubular Necrosis
  • Leads to
  • Loss of cell polarity
  • Brush border loss
  • Impaired cell-cell adhesion
  • Impaired tight junction
  • End results
  • Impaired solute and water transport
  • Sloughing of tubule cells ? obstruction
  • Back leakage of filtrate

28
????????????
  • ??????????????GFR????
  • ? ????????
  • ???????
  • ?????? ????? ?????
  • ???????
  • ? ?????
  • ?????
  • ????
  • ? ?????????

29
Characteristics clinical courses
  • Oliguric phase
  • Diuretic phase
  • Recovery phase

30
Oliguric phase
  • Usually lasting for 1 to 6 weeks,the
    average duration is between 7 10 days.
  • Features of urine I. Oliguria or Anuria
  • II.
    Hematuria and casts
  • III. Low
    specific gravity and osmolality
  • IV.
    Urinary Na above 20mM
  • Azotemia
  • Metabolic acidosis
  • Hyperkalemia
  • Hypervolemia / Hypertension
  • Others edema, water intoxication,tachypnea

31
Urinary Indices in ARF
Prerenal ARF ATN
Urinary Na, mEq/L lt20 gt40
Urine to plasma Cr gt40 lt20
Urine osmolality gt500 lt400
Urine specific gravity gt1.020 lt1.015
Renal Failure Index lt1 gt1
FENa lt1 gt1
Response to IVF Good Poor
32
???????????(ATN)???
  • ?????
    ?????
  • ????
  • ???
  • ????
  • ??
  • ???/???
  • ???
  • ?????

gt1.020 lt1.015
gt500mOsm/L lt400mOsm/L
lt20mmol/L gt40mmol/L
gt40 lt20
?? ??????????????
???????? ???????? ??????,GFR?
????
??? ?????? ??????
??????
???????
33
Muddy Brown Cast
34
Red Cell Cast
35
White Cell Casts
36
Diuretic phase
  • As healing begins, improvement is
    reflected in the production of more than 400 ml
    of urine per day.
  • Fluid and electrolyte abnormalities.
  • Cr may still rise for 1-2 more days.

Recovery phase
37
ARF??????????????
  • ? ???
  • 1. ?????
  • 2. ???????????,??GFR??,?????????????????????
    ?,?????????????(gt28.6mmol/L,?gt40mg/dl)?
  • 3. ???????????????,???????,???????????,??????
    ???,?????????????????????ARF??,??????????
  • 4. ??????GFR????????????,????????????????????
    ??????????,?????????????????????????????????ARF???
    ???????????
  • 5. ?????????GFR??????????????????????????????
    ???????

38
  • ? ???
  • ??????,???????400ml,????????????????????????
    ??????????????,GFR??????,????????????????????????,
    ??????????????,????????????????????,??????????????
    ?????????????,???????????????,?????????????
  • ? ???
  • ????????,?????????????????????,????????????
    ?

39
Nonoliguric acute renal failure
  • ????ARF??????????????????????????????????????????
    ????????? ???????????,??????????????????????
    ???????????????????????? ??????????????,?????????
    ,???????????,?4001000 ml/d???????ARF????ARF??????
    ?,??????????,??????????????????????ARF?????,??????
    ??ARF?

40
Management
  • Renal Diet
  • Acidosis
  • Hyperuricemia
  • Hypertension
  • Volume overload
  • Protein Load
  • Newer AgentsANF
  • Dialysis
  • Kidney Transplantation
  • Hospital inpatients with ARF 50 mortality rate

41
Dialysis indications
  • I. Serum abnormalities unresponsive to medical
    therapy
  • Severe Acidosis
  • Severe Hyperkalemia
  • II. Uremia
  • Mental status changes (usually delirium)
  • Nausea and vomiting
  • Pericarditis (pericardial friction rub)
  • III. Volume Overload

42
Peritoneal Dialysis
43
Hemodialysis
  • Blood is circulated through artificial cellophane
    membrane that permits a similar passage of water
    and solutes

44
Chronic Renal Failure, CRF
45
  • Definition
  • Etiology
  • Pathogenesis
  • Clinical manifestation
  • Therapy

46
Definition
  • Chronic renal failure (CRF) is defined as a
    permanent reduction in glomerular filtration rate
    (GFR) sufficient to produce detectable
    alterations in well-being and organ function.
    This usually occurs at GFR below 25 ml/min.

47
  • CRF is characterized by progressive and
    irreversible loss of large numbers of functioning
    nephrons. Serious clinical symptoms often do not
    occur until the number of functional nephrons
    falls to at least 70 per cent below normal. In
    fact relatively normal blood concentrations of
    most electrolytes and normal body fluid volumes
    can still be maintained until the number of
    functioning nephrons decreases below 20-30percent
    of normal.

48
(No Transcript)
49
??????????
  • ??????????????????????????,???????????????????????
    ??????????????????????????????????????????,???????
    ?????,??????????,???????????????????
  • ??????????????,?????????????,????????????,????????
    ????????,?????????????????????????????????

50
Causes of CRF
  • Any disorder that permanently destroys
    nephrons can result in chronic renal failure.
    Most common causes of CRF are
  • Diabetic nephropathy
  • Hypertensive nephrosclerosis
  • Glomerulonephritis
  • Interstitial nephritis
  • Polycystic kidney disease

51
??????????
  • ???????????????,??????????????????????????,??C
    RF?5060?
  • (1)???????????????????????????????????
  • (2)????????????????
  • (3)??????????????????
  • (4)??????????????
  • (5)??????????

52
Clinical courses of CRF
  • Four stages of decreased renal function may
    be visualized
  •  
  • Silent GFR up to 50 ml/min.
  • Renal insufficiency GFR 25 to 50 ml/min.
  • Renal failure GFR 5/10 to 25 ml/min
  • End-stage renal failure (ESRF) GFR less than
    5/10 ml/min.

53
Stages of Chronic Kidney Disease

54
???????????????
  • ??????? ????
    ????
  • (ml/min)
  • ??? gt50
    ? ????????????

  • ??????????
  • ????
  • ?????? 20-50 ????
    ??????????
  •  
  • ?????? 10-20 ??
    ???????????? ?? ????
  • ???? lt10 ??
    ????????,???
  • ??????

55
Pathogenesis
  • The most intriguing aspect of CRF is that
    compensatory mechanisms allow loss of 90 of GFR
    before manifestations of the uremic syndrome are
    evident. Thus a variety of adaptations
    compensate for the decreased GFR and allow a new
    steady state of external balance to exist, but on
    the other hand contribute to the uremic syndrome.
    In spite of these adaptations, the hallmark of
    CRF is the loss of flexibility in responding to
    challenges to external load of solutes and water.
  • Intact Nephron hypothesis
    Tubulointerstitial cell injury
  • Trade-off hypothesis

56
Intact Nephron Hypothesis
  • Nephrons functioning in diseased kidneys maintain
    glomerulo-tubular balance. That is, filtration
    and net excretion of various substances are
    coordinated. (e.g. with normal renal function,
    usually 50-60 of filtered urea is reabsorbed
    from the tubules. In CRF it may fall to 30 to
    maintain balance).

57
The Magnification Phenomenon
  • although nephrons in diseased kidneys function
    homogeneously, they alter their handling of given
    solutes as needed to maintain balance of these
    solutes. That is, nephrons can magnify their
    excretion of a given solute. (e.g. tubular
    creatinine excretion is lt 10 with normal renal
    function. In CRF it may increase to 30).

58
Trade-off Hypothesis
  • The mechanisms that are magnified to maintain
    individual solute control may have deleterious
    effects on other systems. This trade-off is seen
    in the increased parathyroid hormone (PTH)
    secretion seen in CRF which enhances renal
    phosphorus excretion. PTH has been implicated in
    the pathogenesis of many disturbances of uremia
    (sleep, sex, bone, disease, anemia, lipidemia,
    vascular disease). As renal disease progresses
    and GFR decreases, high level PTH no longer
    maintains the phosphate excretion. The excessive
    PTH may result in further side effects, such as
    osteomalacia, deposit of calcium phosphate salts
    into soft tissue and damage of cardiovascular,
    neural systems.

59
????????????
  • ??????????
  • ????
  • ??? - ????

60
?????????
  • ??????
  •  
  • ????
  •  

  • GFR? GFR?? VitD3?
  • ???

  • ???? ????? ???
  • ????

  • ??????? ????
  •   ???????? PTH?
    ????
  • (?????)
  • ???
    ?? ???????
  •   ??
    ??

61
??? ? ??/?
???????Ccr
???
???90-140ml/min ?????2-3????? ??????????lt40g/
?,???,???????
62
Clinical manifestations of CRF
  • Loss of nephrons function to excrete water and
    solutes.
  • Characteristics of urine
  • urine volume,osmotic gravity, urinary
    sediment
  • Effects on body fluids.
  • water sodium imbalance
  • potassium imbalance
  • metabolic acidosis
  • phosphate calcium metabolism dysfunction
  • azotemia
  • Other signs of CRF
  • cardiovascular abnormalities
  • anemia bleeding
  • renal osteodystrophy

63
Anemia
  • Anemia is universal as GFR falls below
    25 ml/min. in certain disorders it may occur
    with mild renal insufficiency. Several factors
    contribute 
  • a. Erythropoiesis is markedly depressed, mainly
    due to reduced erythropoietin production in
    addition, there may be reduced end-organ response
    to erythropoietin with reduced heme synthesis.
  • b. Red cell survival is shortened with a mild to
    moderate decrease in red cell life span, possible
    due to a uremic toxin.
  • c. Blood loss is common in uremic patients,
    possibly secondary to abnormal coagulation due to
    decreased platelet function.
  • d. Marrow space fibrosis occurs with osteitis
    fibrosa of secondary hyperparathyroidism
    resulting in decreased erythropoiesis.

64
Hypertension
  •   Hypertension occurs in 80 to 90 of
    patients with renal insufficiency. Several
    factors contribute
  • a. Expansion of extracellular fluid volume this
    may arise because of reduced ability of the
    kidney to excrete ingested sodium.
  • b. Increased activity of the renin-angiotensin
    system is common many patients with advanced
    renal failure have renin levels that are not
    completely suppressed by the elevated blood
    pressure.
  • c. Dysfunction of the autonomic nervous system
    occurs with insensitive baroreceptor sensitive
    and with increased sympathetic tone.
  • d. Possible diminished presence of vasodilators
    there may be decreased renal generation of
    prostaglandins or of factors in the
    kallikrein-kinin system.

65
Altered Calcium and Phosphorus Metabolism (Renal
Osteodystrophy)
  •  a. As GFR decreases there is a slight retention
    of phosphorus this phosphorus retention can lead
    to hypocalcemia, which stimulates PTH. The
    latter causes phosphaturia, with restoration of
    serum phosphorus and calcium toward normal.
    However, this occurs only at the expense of
    elevated serum PTH levels. This cycle repeats
    itself in progressive renal failure with PTH
    levels increasing progressively. Ultimately, the
    renal tubule can no longer respond to higher
    levels of PTH with a further decrease in
    phosphorus reabsorption. When this occurs,
    hyperphosphatemia develops, hypocalcemia may
    become prominent and PTH level can increase to
    very high levels. High PTH levels cause bone
    disease with severe osteitis fibrosa.
  • b. Altered vitamin D metabolism occurs secondary
    to decreased renal mass or to phosphate
    retention, with decreased synthesis of 1,25 (OH)2
    D3. This deficiency leads to 1. Diminished
    intestinal absorption of calcium, 2. decreased
    calcemic response of the skeleton to PTH, 3.
    impaired suppression of PTH secretion for any
    increase in serum calcium level, and 4. altered
    collagen synthesis. With advanced renal failure,
    these events can lead to secondary
    hyperparathyroidism and osteomalacia.
  • c. Skeletal resistance to the calcemic action of
    PTH develops thus an increased PTH is required
    to maintain serum calcium at any level.
  • d. Finally, accumulation of aluminum from
    aluminum binding antacids may contribute to the
    bone disease.

66
??????????????
  • 1.??????
  • ?????????????????
  • ????????????????????
  • ??????????????????????????
  • 2.????
  • 3.????????????
  • ???????????????,????????????????????????,?????
    ?????
  • 4.?????(renal hypertension)
  • 5.????(renal anemia)
  • 6.????
  • 7.???????

67
???????????????
  • ????
  •  
  • GFR? ???????
    ?????
  •  
  • ????? ?????
  •  
  • ???? Ald? ?????II?
    ?????


  • PGA2?PGE2???
  • ???? ?????
  •  
  • ????? ???
  •  

68
????????????
  •   ???????
  •  
  • 1,25-(OH)2VitD3
    GFR?
  •  
  • ????? ???
  •  
  • ???? ????
    ???
  •  
  • ?????? PTH???
  •  
    ????? ????
  •  
    ???????
  •  

69
Uremia
70
Concept
  • Uremia, from the Greek urine in the blood, is a
    clinical and biochemical syndrome that occurs
    either abruptly or gradually as renal function
    decreases acutely or chronically. In its extreme
    expression as uremic coma, the patient behaves as
    if poisoned, hypothermia, intermittent seizures,
    a bleeding diathesis,cardiac arrhythmias,
    vomiting, and rapid, shallow respirations may
    appears.

71
Uremia
  • Definition symptomatic azotemia
  • Acidosis ( tachypnea)
  • Mental Status changes
  • Hypervolemia / Hypertension
  • Hyperkalemia
  • Pericarditis

72
???
  • ????????????,???????????????,?????????,???????
    ??????,?????????????,?????(uremia)????????????????
    ?????????

73
Clinical Manifestations
  • The symptoms and signs which constitute
    the uremic syndrome are summarized below
  • Neurological Disorders Fatigue, lethargy, sleep
    disturbances, headache, seizures, encephalopathy,
    peripheral neuropathy including restless leg
    syndrome, paraesthesia, motor weakness,
    paralysis.
  • Hematologic Disorders Anemia, bleeding tendency
    due in part to platelet dysfunction.
  • Cardiovascular Disorders Pericarditis,
    hypertension, congestive heart failure, coronary
    artery disease, myocardiopathy.
  • Pulmonary Disorders Pleuritis, uremic lung.
  • Gastrointestinal Disorders Anorexia, nausea,
    vomiting gastroenteritis, GI bleeding, peptic
    ulcer.

74
  • Metabolic-Endocrine Disorders Glucose
    intolerance, hyperllipidemia, hyperuricemia,
    malnutrition, sexual dysfunction and infertility.
  • Bone, Calcium, Phosphorus Disorders
    Hyperphosphatemia, hypocalcemia, tetany,
    metastatic calcification, secondary
    hyperparathyroidism, 1,25-dihydroxy vitamin D
    deficiency, osteomalacia, osteitis fibrosa,
    osteoporosis, osteosclerosis.
  • Skin Disorders Pruritus, pigmentation, easy
    bruising, uremic frost.
  • Psychological Disorders Depression, anxiety,
    denial, psychosis.
  • Fluid and Electrolyte Disorders Hyponatremia,
    hyperkalemia, hypermagnesemia, metabolic
    acidosis, volume expansion or depletion

75
Principles of treatment for CRF Uremia
  • Conservative management
  • Dialysis
  • Peritoneal dialysis
  • Hemodialysis
  • Renal transplantation

76
case
  • ?8??????????????,???????,??5??,??3?????100ml/d,???
    ???????480µmol/L(????lt178µmol/L),??
    100mmol/L(????lt20mmol/L),????? 1.008?????????????
    ??????,????????,??????????????????????????????????
    ????????????????????????????

77
Treatment of end stage renal failure(ESRF)
  • When GFR falls below 5 ml/min, the patient
    usually can not live without renal replacement
    therapy. Renal replacement therapy includes
    dialysis and kidney transplantation .
  • Various social or medical factors influence
    decisions about peritoneal or hemodialysis, and
    transplantation in the treatment of end-stage
    renal failure. It should also be noted that none
    of the above are panaceas and each, modality is
    associated with complications and failures.

78
  • Azotemia - elevated blood urea nitrogen (BUN
    gt28mg/dL) and creatinine (Crgt1.5mg/dL)
  • Uremia - azotemia with symptoms or signs of renal
    failure
  • End Stage Renal Disease (ESRD) - uremia requiring
    transplantation or dialysis
  • Chronic Renal Failure (CRF) - irreversible kidney
    dysfunction with azotemia gt3 months
  • Creatinine Clearance (CCr) - the rate of
    filtration of creatinine by the kidney (GFR
    marker)
  • Glomerular Filtration Rate (GFR) - the total rate
    of filtration of blood by the kidney

79
The End
80
??????(glomerural filtration rate,GFR)
  • ???????
  • ????????
  • ????????? ??????? ??????
  • ????

81
Glomerular Filtration Rate
GFR Kf (Pgc-PB) - (?gc-?B) Kf (?P-??) Kf
glomerular ultrafiltration coefficient Pgc
glomerular capillary hydraulic pressure PB
Bowmans space hydraulic pressure ?gc
glomerular colloid osmotic pressure ?B Bowmans
space colloid osmotic pressure
82
Estimates of GFR
  • Inulin neither secreted or reabsorbed
  • Clearance of inulin approximates GFR
  • Uinulin V
  • Pinulin
  • Creatine is secreted, so Cr clearance
    overestimates GFR

GFR
83
Estimates of GFR
Urinary Estimate Ucr V Pcr
Cockcroft Gault Estimate 140-age
(yr)body wt (kg) 72Pcr
CrCl
CrCl
84
Glomerulus
85
(No Transcript)
86
Filtration Membrane Electron Micro.
Capillary Space
GBM
Endothelium
Urinary Space
Podocyte
87
(No Transcript)
88
Symptoms of chronic kidney disease
  • Fatigue and weakness (from anemia or accumulation
    of waste products in the body)  
  • Loss of appetite, nausea and vomiting 
  • Need to urinate frequently, especially at night
  • Swelling of the legs and puffiness around the
    eyes (fluid retention)
  • Itching, easy bruising, and pale skin (from
    anemia)
  • Headaches, numbness in the feet or hands
    (peripheral neuropathy), disturbed sleep, altered
    mental status (encephalopathy from the
    accumulation of waste products or uremic
    poisons), and restless legs 
  • High blood pressure, chest pain due to
    pericarditis (inflammation around the heart)
  • Shortness of breath from fluid in lungs
  • Bleeding (poor blood clotting)
  • Bone pain and fractures
  • Decreased sexual interest and erectile
    dysfunction
Write a Comment
User Comments (0)
About PowerShow.com